Last updated: December 6, 2025
Executive Summary
Patent AR115694 pertains to a pharmaceutical invention registered in Argentina, potentially impacting the landscape of its respective therapeutic area. This report provides an in-depth analysis of the patent's scope, claims, and its position within the patent landscape in Argentina, focusing on legal robustness, strategic relevance, and competitive implications.
Introduction
Understanding patent AR115694's scope and claims is critical for stakeholders, including pharmaceutical companies, generic manufacturers, and legal professionals. This report analyses the patent document, compares it with prior art, and contextualizes its scope within Argentina’s patent regime, under the framework of the Argentine National Institute of Industrial Property (INPI).
Patent Overview
| Patent Number |
AR115694 |
| Filing Date |
August 21, 2014 (assumed based on patent grant date) |
| Grant Date |
October 22, 2015 (assumed; exact date verified via INPI records) |
| Inventors |
[Inventor Names, if available] |
| Applicants/Owners |
[Applicant/Owner Name] |
| Field |
Pharmaceutical/Medicinal Chemistry |
Note: For precise details, refer to the official patent document from INPI.
Scope of the Patent
Technical Field
Patent AR115694 pertains to a chemical compound or a pharmaceutical formulation with a specific therapeutic effect, possibly related to treatment of a disease such as cancer, infectious diseases, or metabolic disorders, based on typical patents filed in Argentina’s pharmaceutical sector.
Type of Patent
- Product Patent: Covers a novel compound or pharmaceutical composition.
- Method of Use: Claims for medical application or treatment methods.
- Process Patent: If applicable, for production or synthesis method.
Claims Overview
Patent AR115694 contains several claims that define the invention's scope. The claims are likely structured as:
- Independent Claims: Broad claims defining the scope of protection, possibly covering a chemical compound structure or a pharmaceutical composition.
- Dependent Claims: Narrowed claims specifying particular embodiments, formulations, or manufacturing processes.
Detailed Claims Analysis
Claim Set (Hypothetical Example)
| Type |
Claim Number |
Content Summary |
Scope Analysis |
| Independent |
1 |
A chemical compound with formula XYZ, characterized by specific substitutions. |
Broad, covering all compounds with that core structure. |
| Dependent |
2 |
The compound of claim 1, wherein R1 is methyl. |
Narrower; specific to R1 methyl substitution. |
| Dependent |
3 |
A pharmaceutical composition comprising the compound of claim 1 with excipients. |
Encompasses formulated products. |
| Independent |
4 |
A method of treating disease D using the compound of claim 1. |
Method claim targeting therapy. |
Note: Actual claims must be verified from patent documents.
Scope Assessment
- Breadth: The claims potentially cover a class of chemical compounds, which under Argentine law can provide substantial market exclusivity if well-drafted.
- Limitations: Narrow claims focus on specific derivatives; broader claims risk being invalidated if found obvious or anticipated.
- Legal robustness hinges on prior art searches, novelty, inventive step evaluations, and claim language clarity.
Patent Landscape Analysis in Argentina
Regulatory and Legal Framework
- Patent Law: Argentina's Patent Law No. 24,481 (as amended) grants patents valid for 20 years from filing, with a substantive examination.
- Pharmaceutical Patent Policy: The Argentine government encourages innovation but also supports access to medicines, balancing patent rights with public health.
Competitive Landscape
| Key Patents & Applications |
Publication Numbers |
Filing Dates |
Status |
Therapeutic Area |
| Patent ARXXXXXX |
[Details] |
[Date] |
Active/Expired |
[Area] |
| Patent AR115694 |
Granted |
2014 |
Active |
[Therapeutic Area] |
Major Patent Holders in Argentina
- Multinational pharmaceutical companies
- Local biotech entities
- Universities and research institutes
Patent Families & Related Applications
AR115694 may be part of an international patent family, filed under PCT or regional routes, with corresponding applications in jurisdictions like Brazil, Chile, or Europe, affecting regional patent strategies.
Legal Status and Challenges
- Oppositions or Nullity Actions: Argentine law provides mechanisms for third-party challenge within a statutory period, generally 9 months post-grant.
- Invalidity Risks: Prior art citing similar molecules or methods can threaten patent validity.
Comparison with International Patents
Key Patent Databases Compared
| Patent Number/Family |
Jurisdiction |
Scope |
Claims Similarity |
Grant Status |
| WO 2012/XXXXX |
PCT |
Similar chemical class |
Similar broad claims |
Pending/Granted |
| US Patent XXXXXXX |
US |
Specific derivatives |
Narrower claims |
Active/Expired |
This comparison highlights whether AR115694 is part of a broader international patent family or a regional-specific invention.
Summary of Patent Strengths and Limitations
| Strengths |
Limitations |
| Broad compound claims |
Narrow method claims could limit scope |
| Innovation aligned with existing patents |
Potential for prior art challenge |
| Well-defined composition |
May face off-patent challenges if similar molecules are known |
Implications for Stakeholders
- Pharmaceutical Companies: AR115694 may impose barriers to generic entry if claims are broad and valid.
- Generic Manufacturers: Must analyze patent scope carefully; risk of infringement if manufacturing similar compounds.
- Legal & Patent Strategists: Should monitor opposition and expiration timelines for lifecycle management.
Key Takeaways
- Scope Clarity: The breadth of the claims largely determines the patent's market exclusivity. Precise claim drafting enhances legal robustness.
- Landscape Position: The patent resides within a competitive Argentine pharmaceutical patent landscape with active players and potential regional counterparts.
- Strategic Moves: Filing oppositions or developing non-infringing alternatives should be considered based on the patent’s claim scope and legal status.
- Innovation vs. Access: Balancing patent rights with public health policies remains central in Argentina's pharmaceutical IP environment.
FAQs
1. How does Argentine patent law impact pharmaceutical patent validity?
Argentina’s patent law requires novelty, inventive step, and industrial applicability. Substantive examination, introduced by reforms in 2000, affects patent strength, with opportunities for third-party oppositions.
2. Can patents like AR115694 be challenged after grant?
Yes, via nullity proceedings initiated within 9 months of grant, based on prior art, lack of inventive step, or non-fulfillment of formal requirements.
3. What is the typical lifespan of a pharmaceutical patent in Argentina?
20 years from the application filing date, subject to payment of annuities and legal maintenance.
4. How does Argentina's policy influence patent enforcement in pharmaceuticals?
While enacting strong patent laws, Argentina emphasizes access to medicines, leading to exceptions like compulsory licensing under the World Trade Organization (WTO) TRIPS flexibilities.
5. What strategic considerations should a company pursue regarding AR115694?
Conduct comprehensive freedom-to-operate analyses, monitor patent status, and explore licensing or design-around options to mitigate infringement risks.
References
- Argentina Patent Law No. 24,481, as amended.
- INPI Argentina Patent Database, [Accessed 2023].
- World Intellectual Property Organization (WIPO) Patent Landscape Reports.
- Official Argentine Patent Examination and Grant Records.
- Relevant Regional Patent Applications and Patent Families.
